Using National COVID Cohort Collaborative (N3C) Data to Inform your Protocol Development
Learn how to use the National Institutes of Health‘s National Center for Advancing Translational Science‘s National COVID Cohort Collaborative (N3C) for your COVID-19 trials with the Trial Innovation Network (TIN). N3C is an open science community that aims to find patterns in COVID-19 patients from clinical centers across the country.
This webinar will provide an overview and update on the status of N3C, followed by expert presentations covering N3C for research on pharma-commercial, pharmacoepidemiology, and social determinants of health.
